Coronavirus / COVID

Analysis suggests approach may be particularly useful when testing resources are limited.

Where did things go wrong for the Grand Canyon State?

A high proportion of N95 masks failed to fit properly with the extended use and reuse recommended by the CDC for conserving PPE during the shortage.

Video briefing on the day's top infectious disease news.

Given research into SARS-CoV-2 is taking place at unprecedented speed, the panel of IDSA experts had to decide on current best practices using science which is still in motion.

In a small randomized trial, Greek investigators found patients had improved time to clinical deterioration versus a control group.

Patrick Soon-Shiong, MD, Chairman and CEO of ImmunityBio, explains why the firm's COVID-19 research benefits from drawing on a background in cancer.

A recent review of electronic health data revealed a 42% drop in emergency department visits during 4 weeks of the pandemic.

An overview of today's top infectious disease stories.

Patrick Soon-Shiong, MD, CEO of ImmunityBio, discusses the pandemic as a unique moment in world & American history.

In order to expand the potential uses of the drug against SARS-CoV-2, Gilead Sciences has announced plans to explore administration of remdesivir in an inhaled form.

Thomas File, Jr. MD, MSc, FIDSA, president of the Infectious Diseases Society of America, weighs in on COVID vaccine development, fears of a second wave, and treatment candidates.

A video summary of the latest infectious disease headlines.

With the current COVID-19 outbreak, new data about Influenza mortality related to spectator sports should make the professional leagues and fans pause about attending games.

Compared to 2019, out-of-hospitalization cardiac arrest resuscitations saw a dramatic increase as well as differences in the types of patients experiencing these episodes.

Findings reveal that most unhealthy seniors and/or their families opt for comfort-directed care rather than life-sustaining treatment.

A June 19, 2020 recap of the biggest headlines in pandemic research and response.

A telephone survey confirms people are dealing with these issues and suggests it may be an early bellwether to providers and patients alike.

Steven Woloshin, MD, MS, discusses a recently authored article in the New England Journal of Medicine describing the challenges and implications of false negative tests for SARS-CoV-2 infection.

In a recent US survey, African American male participants knew more people infected with COVID-19, had greater knowledge disparities, and were exposed to the virus more than other groups.

Health officials are urging parents to adhere to recommended vaccination schedules amid the COVID-19 pandemic, which has led to a drop in vaccination coverage.

A video review of the latest ID news.

Vibeke Strand, MD, MACR, FACP, of the Division of Immunology/Rheumatology at Stanford University School of Medicine, discusses ongoing AI research in her field.

the company announced it COVID-19 medication is looking to address viral replication and uncontrolled inflammatory response.

In a new analysis of Guangzhou city contact tracing data, investigators examined secondary attack rates of SARS-CoV-2.

An overview of 3 recent infectious disease news stories.

A modeling study from the UK reinforces how the transmission rates from infected people can be lowered using a variety of well-known strategies.

Final Diagnosis: Infective Endocarditis Due to Granulicatella adiacens and Streptococcus mitis.

Vibeke Strand, MD, MACR, FACP, discusses patients who are having a hard time getting their usual supplies of HCQ.

Given there is not a clear international standard for health records, one of the challenges in the early COVID-19 response mobilization was a delayed start to data collection and indexing.